A novel interaction between the 5' untranslated region of the Chikungunya virus genome and Musashi RNA binding protein is essential for efficient virus genome replication

Nucleic Acids Res. 2024 Sep 23;52(17):10654-10667. doi: 10.1093/nar/gkae619.

Abstract

Chikungunya virus (CHIKV) is a re-emerging, pathogenic alphavirus that is transmitted to humans by Aedesspp. mosquitoes-causing fever and debilitating joint pain, with frequent long-term health implications and high morbidity. The CHIKV replication cycle is poorly understood and specific antiviral therapeutics are lacking. In the current study, we identify host cell Musashi RNA binding protein-2 (MSI-2) as a proviral factor. MSI-2 depletion and small molecule inhibition assays demonstrated that MSI-2 is required for efficient CHIKV genome replication. Depletion of both MSI-2 and MSI-1 homologues was found to synergistically inhibit CHIKV replication, suggesting redundancy in their proviral function. Electromobility shift assay (EMSA) competition studies demonstrated that MSI-2 interacts specifically with an RNA binding motif within the 5' untranslated region (5'UTR) of CHIKV and reverse genetic analysis showed that mutation of the binding motif inhibited genome replication and blocked rescue of mutant virus. For the first time, this study identifies the proviral role of MSI RNA binding proteins in the replication of the CHIKV genome, providing important new insight into mechanisms controlling replication of this significant human pathogen and the potential of a novel therapeutic target.

MeSH terms

  • 5' Untranslated Regions* / genetics
  • Animals
  • Cell Line
  • Chikungunya Fever / genetics
  • Chikungunya Fever / virology
  • Chikungunya virus* / genetics
  • Genome, Viral*
  • HEK293 Cells
  • Humans
  • Protein Binding
  • RNA, Viral / genetics
  • RNA, Viral / metabolism
  • RNA-Binding Proteins* / genetics
  • RNA-Binding Proteins* / metabolism
  • Virus Replication* / genetics

Substances

  • RNA-Binding Proteins
  • 5' Untranslated Regions
  • RNA, Viral

Grants and funding